AAAAAA

   
Results: 1-25 | 26-36
Results: 1-25/36
PHARMACOKINETICS OF LUBELUZOLE (PROSYNAP) AFTER SINGLE INTRAVENOUS DOSES IN HEALTHY-SUBJECTS
Authors: VANDEVELDE V CRABBE R VANPEER A WOESTENBORGHS R VANOSSELAER N HANTSON L HEYKANTS J
Citation: V. Vandevelde et al., PHARMACOKINETICS OF LUBELUZOLE (PROSYNAP) AFTER SINGLE INTRAVENOUS DOSES IN HEALTHY-SUBJECTS, International journal of clinical pharmacology and therapeutics, 36(9), 1998, pp. 490-493
ITRACONAZOLE PULSE THERAPY IS EFFECTIVE IN THE TREATMENT OF MAJOCCHIS-GRANULOMA - A CLINICAL AND PHARMACOKINETIC EVALUATION AND IMPLICATIONS FOR POSSIBLE EFFECTIVENESS IN TINEA-CAPITIS
Authors: GUPTA AK GROEN K WOESTENBORGHS R DEDONCKER P
Citation: Ak. Gupta et al., ITRACONAZOLE PULSE THERAPY IS EFFECTIVE IN THE TREATMENT OF MAJOCCHIS-GRANULOMA - A CLINICAL AND PHARMACOKINETIC EVALUATION AND IMPLICATIONS FOR POSSIBLE EFFECTIVENESS IN TINEA-CAPITIS, Clinical and experimental dermatology, 23(3), 1998, pp. 103-108
DETERMINATION OF THE DOSE PROPORTIONALITY OF SINGLE INTRAVENOUS DOSES(5, 10, AND 15 MG) OF LUBELUZOLE IN HEALTHY-VOLUNTEERS
Authors: HERRON J LEE P PESCOKOPLOWITZ L GAJJAR D SOO YW WOESTENBORGHS R
Citation: J. Herron et al., DETERMINATION OF THE DOSE PROPORTIONALITY OF SINGLE INTRAVENOUS DOSES(5, 10, AND 15 MG) OF LUBELUZOLE IN HEALTHY-VOLUNTEERS, Clinical therapeutics, 20(4), 1998, pp. 682-690
A PHARMACOKINETIC STUDY OF INTRAVENOUS ITRACONAZOLE FOLLOWED BY ORAL-ADMINISTRATION OF ITRACONAZOLE CAPSULES IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: ZHOU HH GOLDMAN M WU J WOESTENBORGHS R HASSELL AE LEE P BARUCH A PESCOKOPLOWITZ L BORUM J WHEAT LJ
Citation: Hh. Zhou et al., A PHARMACOKINETIC STUDY OF INTRAVENOUS ITRACONAZOLE FOLLOWED BY ORAL-ADMINISTRATION OF ITRACONAZOLE CAPSULES IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Journal of clinical pharmacology, 38(7), 1998, pp. 593-602
ABSOLUTE BIOAVAILABILITY OF LEVOCABASTINE IN HEALTHY-VOLUNTEERS AFTERA SINGLE INTRANASAL DOSE
Authors: ZHOU H HASSELL A LEE P TRAVERS S WOESTENBORGHS R PESCOKOPLOWITZ L
Citation: H. Zhou et al., ABSOLUTE BIOAVAILABILITY OF LEVOCABASTINE IN HEALTHY-VOLUNTEERS AFTERA SINGLE INTRANASAL DOSE, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 29-29
LUBELUZOLE PHARMACOKINETICS IN SUBJECTS WITH MILD, MODERATE AND SEVERE RENAL IMPAIRMENT
Authors: BURSTEIN AH LEE PID GAJJAR D ZHOU H SOO Y PESCOKOPLOWITZ L HANTSON L WOESTENBORGHS R YOUNG D
Citation: Ah. Burstein et al., LUBELUZOLE PHARMACOKINETICS IN SUBJECTS WITH MILD, MODERATE AND SEVERE RENAL IMPAIRMENT, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 68-68
POPULATION ANALYSIS OF THE NON-LINEAR RED-BLOOD-CELL PARTITIONING ANDTHE CONCENTRATION-EFFECT RELATIONSHIP OF DRAFLAZINE FOLLOWING VARIOUSINFUSION RATES
Authors: SNOECK E PIOTROVSKIJ V JACQMIN P VANPEER A DANHOF M DONCK KV WOESTENBORGHS R VANBELLE H VANBORTEL L VANGOOL R DUPONT AG HEYKANTS J
Citation: E. Snoeck et al., POPULATION ANALYSIS OF THE NON-LINEAR RED-BLOOD-CELL PARTITIONING ANDTHE CONCENTRATION-EFFECT RELATIONSHIP OF DRAFLAZINE FOLLOWING VARIOUSINFUSION RATES, British journal of clinical pharmacology, 43(6), 1997, pp. 603-612
INFLUENCE OF ITRACONAZOLE ON THE PHARMACOKINETICS AND ELECTROCARDIOGRAPHIC EFFECTS OF ASTEMIZOLE
Authors: LEFEBVRE RA VANPEER A WOESTENBORGHS R
Citation: Ra. Lefebvre et al., INFLUENCE OF ITRACONAZOLE ON THE PHARMACOKINETICS AND ELECTROCARDIOGRAPHIC EFFECTS OF ASTEMIZOLE, British journal of clinical pharmacology, 43(3), 1997, pp. 319-322
RISPERIDONE - EFFECTS OF FORMULATIONS ON ORAL BIOAVAILABILITY
Authors: GUTIERREZ R LEE PID HUANG ML WOESTENBORGHS R
Citation: R. Gutierrez et al., RISPERIDONE - EFFECTS OF FORMULATIONS ON ORAL BIOAVAILABILITY, Pharmacotherapy, 17(3), 1997, pp. 599-605
INHIBITION OF PANCREATICOBILIARY SECRETION BY LOPERAMIDE IN HUMANS
Authors: THIMISTER PWL HOPMAN WPM VANROERMUND RFC WILLEMS HL ROSENBUSCH G WOESTENBORGHS R JANSEN JBMJ
Citation: Pwl. Thimister et al., INHIBITION OF PANCREATICOBILIARY SECRETION BY LOPERAMIDE IN HUMANS, Hepatology, 26(2), 1997, pp. 256-261
SAFETY AND PHARMACOKINETICS OF THE NEUROPROTECTIVE DRUG LUBELUZOLE INPATIENTS WITH ISCHEMIC STROKE
Authors: DEKEYSER J VANDEVELDE V SCHELLENS RLLA HANTSON L TRITSMANS L GHEUENS J VANPEER A WOESTENBORGHS R FRANKE CL VANGORP J
Citation: J. Dekeyser et al., SAFETY AND PHARMACOKINETICS OF THE NEUROPROTECTIVE DRUG LUBELUZOLE INPATIENTS WITH ISCHEMIC STROKE, Clinical therapeutics, 19(6), 1997, pp. 1340-1351
CONCENTRATIONS IN PLASMA AND SAFETY OF 7 DAYS OF INTRAVENOUS ITRACONAZOLE FOLLOWED BY 2 WEEKS OF ORAL ITRACONAZOLE SOLUTION IN PATIENTS IN INTENSIVE-CARE UNITS
Authors: VANDEWOUDE K VOGELAERS D DECRUYENAERE J JAQMIN P DEBEULE K VANPEER A WOESTENBORGHS R GROEN K COLARDYN F
Citation: K. Vandewoude et al., CONCENTRATIONS IN PLASMA AND SAFETY OF 7 DAYS OF INTRAVENOUS ITRACONAZOLE FOLLOWED BY 2 WEEKS OF ORAL ITRACONAZOLE SOLUTION IN PATIENTS IN INTENSIVE-CARE UNITS, Antimicrobial agents and chemotherapy, 41(12), 1997, pp. 2714-2718
POPULATION ANALYSIS OF THE NONLINEAR RED-BLOOD-CELL PARTITIONING OF DRAFLAZINE FOLLOWING VARIOUS INFUSION DURATIONS
Authors: SNOECK E PIOTROVSKIJ V JACQMIN P LINS RL VANPEER A DANHOF M WOESTENBORGHS R VANGOOL R DUPONT AG HEYKANTS J
Citation: E. Snoeck et al., POPULATION ANALYSIS OF THE NONLINEAR RED-BLOOD-CELL PARTITIONING OF DRAFLAZINE FOLLOWING VARIOUS INFUSION DURATIONS, European Journal of Clinical Pharmacology, 53(1), 1997, pp. 57-63
PHARMACOKINETIC STUDY AND CARDIOVASCULAR MONITORING OF NEBIVOLOL IN NORMAL AND OBESE SUBJECTS
Authors: CHEYMOL G WOESTENBORGHS R SNOECK E IANUCCI R LEMOING JP NADITCH L LEVRON JC POIRIER JM
Citation: G. Cheymol et al., PHARMACOKINETIC STUDY AND CARDIOVASCULAR MONITORING OF NEBIVOLOL IN NORMAL AND OBESE SUBJECTS, European Journal of Clinical Pharmacology, 51(6), 1997, pp. 493-498
THE EFFECT OF COADMINISTRATION OF A COLA BEVERAGE ON THE BIOAVAILABILITY OF ITRACONAZOLE IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME
Authors: LANGE D PAVAO JH JACQMIN P WOESTENBORGHS R DING C KLAUSNER M
Citation: D. Lange et al., THE EFFECT OF COADMINISTRATION OF A COLA BEVERAGE ON THE BIOAVAILABILITY OF ITRACONAZOLE IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME, Current therapeutic research, 58(3), 1997, pp. 202-212
THE PHARMACOKINETICS OF LEVAMISOLE IN PATIENTS WITH HEPATIC IMPAIRMENT
Authors: REISS WG BURSTEIN AH LEE PID PESCOKOPLOWITZ LRC OUYANG P WOESTENBORGHS R KREMER A YOUNG D
Citation: Wg. Reiss et al., THE PHARMACOKINETICS OF LEVAMISOLE IN PATIENTS WITH HEPATIC IMPAIRMENT, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 73-73
THE IMPLICATIONS OF NONLINEAR RED-BLOOD-CELL PARTITIONING FOR THE PHARMACOKINETICS AND PHARMACODYNAMICS OF THE NUCLEOSIDE TRANSPORT INHIBITOR DRAFLAZINE
Authors: SNOECK E JACQMIN P VANPEER A DANHOF M VERDONCK K VANBELLE H WOESTENBORGHS R CRABBE R VANGOOL R DUPONT A HEYKANTS J
Citation: E. Snoeck et al., THE IMPLICATIONS OF NONLINEAR RED-BLOOD-CELL PARTITIONING FOR THE PHARMACOKINETICS AND PHARMACODYNAMICS OF THE NUCLEOSIDE TRANSPORT INHIBITOR DRAFLAZINE, British journal of clinical pharmacology, 42(5), 1996, pp. 605-613
ANTIFUNGAL PULSE THERAPY FOR ONYCHOMYCOSIS - A PHARMACOKINETIC AND PHARMACODYNAMIC INVESTIGATION OF MONTHLY CYCLES OF 1-WEEK PULSE THERAPY WITH ITRACONAZOLE
Authors: DEDONCKER P DECROIX J PIERARD GE ROELANT D WOESTENBORGHS R JACQMIN P ODDS F HEREMANS A DOCKX P ROSEEUW D
Citation: P. Dedoncker et al., ANTIFUNGAL PULSE THERAPY FOR ONYCHOMYCOSIS - A PHARMACOKINETIC AND PHARMACODYNAMIC INVESTIGATION OF MONTHLY CYCLES OF 1-WEEK PULSE THERAPY WITH ITRACONAZOLE, Archives of dermatology, 132(1), 1996, pp. 34-41
THE PHARMACOKINETICS OF CONTINUOUS EPIDURAL SUFENTANIL AND BUPIVACAINE INFUSION AFTER THORACOTOMY
Authors: HANSDOTTIR V WOESTENBORGHS R NORDBERG G
Citation: V. Hansdottir et al., THE PHARMACOKINETICS OF CONTINUOUS EPIDURAL SUFENTANIL AND BUPIVACAINE INFUSION AFTER THORACOTOMY, Anesthesia and analgesia, 83(2), 1996, pp. 401-406
INFLUENCE OF AGE, RENAL AND LIVER IMPAIRMENT ON THE PHARMACOKINETICS OF RISPERIDONE IN MAN
Authors: SNOECK E VANPEER A SACK M HORTON M MANNENS G WOESTENBORGHS R MEIBACH R HEYKANTS J
Citation: E. Snoeck et al., INFLUENCE OF AGE, RENAL AND LIVER IMPAIRMENT ON THE PHARMACOKINETICS OF RISPERIDONE IN MAN, Psychopharmacology, 122(3), 1995, pp. 223-229
THE PHARMACOKINETIC PROPERTIES OF TOPICAL LEVOCABASTINE - A REVIEW
Authors: HEYKANTS J VANPEER A VANDEVELDE V SNOECK E MEULDERMANS W WOESTENBORGHS R
Citation: J. Heykants et al., THE PHARMACOKINETIC PROPERTIES OF TOPICAL LEVOCABASTINE - A REVIEW, Clinical pharmacokinetics, 29(4), 1995, pp. 221-230
REDUCTION OF THE PRODRUG LOPERAMIDE OXIDE TO ITS ACTIVE-DRUG LOPERAMIDE IN THE GUT OF RATS, DOGS, AND HUMANS
Authors: LAVRIJSEN K VANDYCK D VANHOUDT J HENDRICKX J MONBALIU J WOESTENBORGHS R MEULDERMANS W HEYKANTS J
Citation: K. Lavrijsen et al., REDUCTION OF THE PRODRUG LOPERAMIDE OXIDE TO ITS ACTIVE-DRUG LOPERAMIDE IN THE GUT OF RATS, DOGS, AND HUMANS, Drug metabolism and disposition, 23(3), 1995, pp. 354-362
LOPERAMIDE INHIBITS BASAL AND AMINO-ACID STIMULATED PANCREATIC-ENZYMESECRETION IN MAN
Authors: THIMISTER PWL HOPMAN WPM WILLEMS JL WOESTENBORGHS R JANSEN JBMJ
Citation: Pwl. Thimister et al., LOPERAMIDE INHIBITS BASAL AND AMINO-ACID STIMULATED PANCREATIC-ENZYMESECRETION IN MAN, Gastroenterology, 108(4), 1995, pp. 396-396
EFFECT OF LOPERAMIDE ON BASAL AND AMINO-ACID STIMULATED PLASMA CHOLECYSTOKININ AND GALLBLADDER EMPTYING IN HUMANS
Authors: THIMISTER PWL HOPMAN WPM ROSENBUSCH G WILLEMS JL WOESTENBORGHS R JANSEN JBMJ
Citation: Pwl. Thimister et al., EFFECT OF LOPERAMIDE ON BASAL AND AMINO-ACID STIMULATED PLASMA CHOLECYSTOKININ AND GALLBLADDER EMPTYING IN HUMANS, Gastroenterology, 108(4), 1995, pp. 439-439
LINEARITY OF PHARMACOKINETICS AND MODEL ESTIMATION OF SUFENTANIL
Authors: GEPTS E SHAFER SL CAMU F STANSKI DR WOESTENBORGHS R VANPEER A HEYKANTS JJP
Citation: E. Gepts et al., LINEARITY OF PHARMACOKINETICS AND MODEL ESTIMATION OF SUFENTANIL, Anesthesiology, 83(6), 1995, pp. 1194-1204
Risultati: 1-25 | 26-36